Analyst says Maravai LifeSciences is not immune to macro headwinds as…
Maravai LifeSciences Holdings Inc MRVI First-quarter revenue fell 68% year over year to $79 millionsomething below that consensus of $79.72 million. Nucleic acid
Home » Lifesciences
Maravai LifeSciences Holdings Inc MRVI First-quarter revenue fell 68% year over year to $79 millionsomething below that consensus of $79.72 million. Nucleic acid
Edwards Lifesciences Corp EW reported Q4 Adjusted EPS of $0.6425% Y/Y and higher than consensus at $0.61. The company reported fourth-quarter revenue of $1.35
A new analysis from The Schiller Kessler Group of national mortality data has found that preventable injury claimed 197,449 American lives in 2024, an average
Traffic surrounding a major stadium event can begin hours before the first spectator enters the venue and continue well after the crowd has gone home.
Every business hits a ceiling determined not by market size, competitive dynamics, or capital availability — but by the number of hours its owner can